{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:56:26Z","timestamp":1790776586789,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"vor","delay-in-days":89,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>While metabolic syndrome (MetS) is a well-established driver of cognitive decline, conventional dichotomous diagnostic criteria fail to capture the cumulative and synergistic allostatic load of metabolic dysfunction. We investigated the longitudinal association between an age- and sex-standardized continuous MetS severity score and risk of incident dementia in a nationally Chinese cohort.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This prospective analysis utilized data from the China Health and Retirement Longitudinal Study. A continuous MetS score was calculated at baseline integrating waist circumference, triglycerides, high-density lipoprotein cholesterol, mean arterial pressure, and fasting blood glucose via validated linear models, and then quartiled (lowest quartile as reference). Incident dementia was ascertained during the Wave 4 follow-up using a rigorous, multidimensional diagnostic protocol. The dose\u2013response relationship was evaluated using restricted cubic splines (RCS) and logistic regression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among 4,920 dementia-free participants at baseline, 667 (13.56%) developed dementia over the follow-up. RCS modeling revealed a significant, linear dose\u2013response association between increasing MetS scores and dementia risk. Each 1-SD increment in the MetS score was independently associated with a 12% higher risk of dementia (OR\u2009=\u20091.12, 95% CI: 1.01\u20131.24). Participants in the highest quartile group faced a 48% increased risk compared to those in the lowest quartile (OR\u2009=\u20091.48, 95% CI: 1.07\u20132.04). This risk amplification was uniquely pronounced among non-obese individuals (BMI\u2009&lt;\u200924 kg\/m\n                      <jats:sup>2<\/jats:sup>\n                      ; P-interaction\u2009=\u20090.378).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>An elevated continuous MetS score is a robust, independent predictor of incident dementia in middle-aged and older adults. Transitioning from binary criteria to a continuous MetS metric provides a nuanced, dose-dependent assessment of dementia risk.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12883-026-05054-6","type":"journal-article","created":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T13:46:09Z","timestamp":1783086369000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association between continuous metabolic syndrome score and incident dementia: a longitudinal study of middle-aged and older Chinese adults"],"prefix":"10.1186","volume":"26","author":[{"given":"Ling","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaofeng","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,3]]},"reference":[{"key":"5054_CR1","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1186\/s12916-025-04169-w","volume":"23","author":"M Hao","year":"1990","unstructured":"Hao M. Trend analysis and future predictions of global burden of Alzheimer\u2019s disease and other dementias: a study based on the global burden of disease database from 1990 to 2021. BMC Med. 1990;23:378. https:\/\/doi.org\/10.1186\/s12916-025-04169-w.","journal-title":"BMC Med"},{"key":"5054_CR2","doi-asserted-by":"publisher","first-page":"43","DOI":"10.31887\/DCNS.2019.21.1\/rperneczky","volume":"21","author":"R Perneczky","year":"2019","unstructured":"Perneczky R. Dementia treatment versus prevention. Dialogues Clin Neurosci. 2019;21:43\u201351. https:\/\/doi.org\/10.31887\/DCNS.2019.21.1\/rperneczky.","journal-title":"Dialogues Clin Neurosci"},{"key":"5054_CR3","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.2337\/dc24-0537","volume":"47","author":"D Qureshi","year":"2024","unstructured":"Qureshi D, Topiwala A, Al Abid SU, et al. Association of metabolic syndrome with neuroimaging and cognitive outcomes in the UK Biobank. Diabetes Care. 2024;47:1415\u201323. https:\/\/doi.org\/10.2337\/dc24-0537.","journal-title":"Diabetes Care"},{"key":"5054_CR4","doi-asserted-by":"crossref","unstructured":"Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106:3143\u20133421.","DOI":"10.1161\/circ.106.25.3143"},{"key":"5054_CR5","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/j.1464-5491.2006.01858.x","volume":"23","author":"KG Alberti","year":"2006","unstructured":"Alberti KG, Zimmet P. Metabolic syndrome--a new world-wide definition. A consensus statement from the international diabetes federation. Diabet Med. 2006;23:469\u201380. https:\/\/doi.org\/10.1111\/j.1464-5491.2006.01858.x.","journal-title":"Diabet Med"},{"issue":"625\u2013637","key":"5054_CR6","doi-asserted-by":"publisher","first-page":"20190215","DOI":"10.1016\/j.jagp.2019.01.214","volume":"27","author":"AR Atti","year":"2019","unstructured":"Atti AR, Valente S, Iodice A, et al. Metabolic syndrome, mild cognitive impairment, and dementia: a meta-analysis of longitudinal studies. American J Geriatr Psychiatry. 2019;27(625\u2013637):20190215. https:\/\/doi.org\/10.1016\/j.jagp.2019.01.214.","journal-title":"American J Geriatr Psychiatry"},{"issue":"198","key":"5054_CR7","doi-asserted-by":"publisher","first-page":"20250823","DOI":"10.1186\/s13195-025-01825-4","volume":"17","author":"D Qureshi","year":"2025","unstructured":"Qureshi D, Allen NE, Ku\u017ama E, et al. Metabolic syndrome and risk of incident all-cause dementia, Alzheimer\u2019s disease and vascular dementia: a systematic review and meta-analysis of longitudinal studies. Alzheimer\u2019s Res Ther. 2025;17(198):20250823. https:\/\/doi.org\/10.1186\/s13195-025-01825-4.","journal-title":"Alzheimer's Res Ther"},{"key":"5054_CR8","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.2337\/diacare.28.9.2289","volume":"28","author":"R Kahn","year":"2005","unstructured":"Kahn R, Buse J, Ferrannini E, et al. The metabolic syndrome: time for a critical appraisal: joint statement from the American diabetes association and the european association for the study of diabetes. Diabetes Care. 2005;28:2289\u2013304. https:\/\/doi.org\/10.2337\/diacare.28.9.2289.","journal-title":"Diabetes Care"},{"issue":"6988","key":"5054_CR9","doi-asserted-by":"publisher","first-page":"20231101","DOI":"10.1038\/s41467-023-42423-y","volume":"14","author":"S Yang","year":"2023","unstructured":"Yang S, Yu B, Yu W, et al. Development and validation of an age-sex-ethnicity-specific metabolic syndrome score in the Chinese adults. Nat Commun. 2023;14(6988):20231101. https:\/\/doi.org\/10.1038\/s41467-023-42423-y.","journal-title":"Nat Commun"},{"issue":"17","key":"5054_CR10","doi-asserted-by":"publisher","first-page":"20080605","DOI":"10.1186\/1475-2840-7-17","volume":"7","author":"JC Eisenmann","year":"2008","unstructured":"Eisenmann JC. On the use of a continuous metabolic syndrome score in pediatric research. Cardiovasc Diabetol. 2008;7(17):20080605. https:\/\/doi.org\/10.1186\/1475-2840-7-17.","journal-title":"Cardiovasc Diabetol"},{"issue":"2421\u20132430","key":"5054_CR11","doi-asserted-by":"publisher","first-page":"20181001","DOI":"10.2337\/dc18-1079","volume":"41","author":"MD DeBoer","year":"2018","unstructured":"DeBoer MD, Filipp SL, Gurka MJ. Use of a metabolic syndrome severity z score to track risk during treatment of prediabetes: an analysis of the diabetes prevention program. Diabetes Care. 2018;41(2421\u20132430):20181001. https:\/\/doi.org\/10.2337\/dc18-1079.","journal-title":"Diabetes Care"},{"key":"5054_CR12","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1007\/978-3-030-22009-9_333","volume-title":"Encyclopedia of Gerontology and Population Aging","author":"X Chen","year":"2021","unstructured":"Chen X, Wang Y, Strauss J, et al. China Health and Retirement Longitudinal Study (CHARLS). In: Gu D, Dupre ME, editors., et al., Encyclopedia of Gerontology and Population Aging. Cham: Springer International Publishing; 2021. p. 948\u201356."},{"issue":"61\u201368","key":"5054_CR13","doi-asserted-by":"publisher","first-page":"20121212","DOI":"10.1093\/ije\/dys203","volume":"43","author":"Y Zhao","year":"2014","unstructured":"Zhao Y, Hu Y, Smith JP, et al. Cohort profile: the China Health and Retirement Longitudinal Study (CHARLS). Int J Epidemiol. 2014;43(61\u201368):20121212. https:\/\/doi.org\/10.1093\/ije\/dys203.","journal-title":"Int J Epidemiol"},{"key":"5054_CR14","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/s12916-021-02024-2","volume":"19","author":"C Sun","year":"2021","unstructured":"Sun C, Li K, Xu H, et al. Association of healthy lifestyle score with all-cause mortality and life expectancy: a city-wide prospective cohort study of cancer survivors. BMC Med. 2021;19:158. https:\/\/doi.org\/10.1186\/s12916-021-02024-2.","journal-title":"BMC Med"},{"issue":"e2241714","key":"5054_CR15","doi-asserted-by":"publisher","first-page":"20221101","DOI":"10.1001\/jamanetworkopen.2022.41714","volume":"5","author":"L Lin","year":"2022","unstructured":"Lin L, Cao B, Chen W, et al. Association of adverse childhood experiences and social isolation with later-life cognitive function among adults in China. JAMA Netw Open. 2022;5(e2241714):20221101. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.41714.","journal-title":"JAMA Netw Open"},{"key":"5054_CR16","doi-asserted-by":"publisher","first-page":"j2856","DOI":"10.1136\/bmj.j2856","volume":"358","author":"S Ahmadi-Abhari","year":"2002","unstructured":"Ahmadi-Abhari S, Guzman-Castillo M, Bandosz P, et al. Temporal trend in dementia incidence since 2002 and projections for prevalence in England and Wales to 2040: modelling study. BMJ. 2002;358:j2856. https:\/\/doi.org\/10.1136\/bmj.j2856.","journal-title":"BMJ"},{"key":"5054_CR17","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12916-023-03147-4","volume":"22","author":"Y Huang","year":"2024","unstructured":"Huang Y, Chen H, Gao M, et al. Self- and interviewer-reported cognitive problems in relation to cognitive decline and dementia: results from two prospective studies. BMC Med. 2024;22:23. https:\/\/doi.org\/10.1186\/s12916-023-03147-4.","journal-title":"BMC Med"},{"key":"5054_CR18","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1186\/1471-2458-8-219","volume":"8","author":"MJ Prince","year":"2008","unstructured":"Prince MJ, de Rodriguez JL, Noriega L, et al. The 10\/66 dementia research group\u2019s fully operationalised DSM-IV dementia computerized diagnostic algorithm, compared with the 10\/66 dementia algorithm and a clinician diagnosis: a population validation study. BMC Public Health. 2008;8:219. https:\/\/doi.org\/10.1186\/1471-2458-8-219.","journal-title":"BMC Public Health"},{"key":"5054_CR19","doi-asserted-by":"publisher","first-page":"120472","DOI":"10.1016\/j.atherosclerosis.2025.120472","volume":"409","author":"M Tee","year":"2025","unstructured":"Tee M, Dijsselhof MBJ, Chong EJY, et al. Effect of metabolic syndrome severity on cerebral haemodynamics and cognition in community-based cohort. Atherosclerosis. 2025;409:120472. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2025.120472.","journal-title":"Atherosclerosis"},{"key":"5054_CR20","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/s41572-024-00563-5","volume":"10","author":"IJ Neeland","year":"2024","unstructured":"Neeland IJ, Lim S, Tchernof A, et al. Metabolic syndrome. Nat Rev Dis Primers. 2024;10:77. https:\/\/doi.org\/10.1038\/s41572-024-00563-5.","journal-title":"Nat Rev Dis Primers"},{"key":"5054_CR21","doi-asserted-by":"publisher","first-page":"100585","DOI":"10.1016\/j.obmed.2025.100585","volume":"54","author":"DE Uti","year":"2025","unstructured":"Uti DE, Atangwho IJ, Omang WA, et al. Cytokines as key players in obesity low grade inflammation and related complications. Obes Med. 2025;54:100585. https:\/\/doi.org\/10.1016\/j.obmed.2025.100585.","journal-title":"Obes Med"},{"key":"5054_CR22","doi-asserted-by":"publisher","first-page":"2790","DOI":"10.3390\/cells10102790","volume":"10","author":"G Ogunmokun","year":"2021","unstructured":"Ogunmokun G, Dewanjee S, Chakraborty P, et al. The potential role of cytokines and growth factors in the pathogenesis of Alzheimer\u2019s disease. Cells. 2021;10:2790. https:\/\/doi.org\/10.3390\/cells10102790.","journal-title":"Cells"},{"key":"5054_CR23","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/s1474-4422(20)30231-3","volume":"19","author":"D Kellar","year":"2020","unstructured":"Kellar D, Craft KDA. Brain insulin resistance in Alzheimer\u2019s disease and related disorders: mechanisms and therapeutic approaches. Lancet Neurol. 2020;19:758\u201366. https:\/\/doi.org\/10.1016\/s1474-4422(20)30231-3.","journal-title":"Lancet Neurol"},{"key":"5054_CR24","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.neuron.2025.10.018","volume":"114","author":"SM Schaeffer","year":"2026","unstructured":"Schaeffer SM, Pacholko AG, Santisteban MM, et al. Hypertension-induced neurovascular and cognitive dysfunction at single-cell resolution. Neuron. 2026;114:422\u201343. https:\/\/doi.org\/10.1016\/j.neuron.2025.10.018.","journal-title":"Neuron"},{"key":"5054_CR25","doi-asserted-by":"publisher","first-page":"104820","DOI":"10.1016\/j.mvr.2025.104820","volume":"160","author":"C Chen","year":"2025","unstructured":"Chen C, Xu X, Lu J, et al. Hyperglycemia-induced blood-brain barrier dysfunction: mechanisms and therapeutic interventions. Microvasc Res. 2025;160:104820. https:\/\/doi.org\/10.1016\/j.mvr.2025.104820.","journal-title":"Microvasc Res"},{"key":"5054_CR26","doi-asserted-by":"publisher","first-page":"20251202","DOI":"10.3390\/jcm14238543","volume":"14","author":"EC Guse","year":"2025","unstructured":"Guse EC, Cotet IG, Mateescu DM, et al. Peripheral microvascular and endothelial dysfunction as predictors of cognitive decline and small vessel disease: a systematic review and meta-analysis. J Clin Med. 2025;14:20251202. https:\/\/doi.org\/10.3390\/jcm14238543.","journal-title":"J Clin Med"},{"issue":"93","key":"5054_CR27","doi-asserted-by":"publisher","first-page":"20230612","DOI":"10.1186\/s40478-023-01590-1","volume":"11","author":"V Rajeev","year":"2023","unstructured":"Rajeev V, Chai YL, Poh L, et al. Chronic cerebral hypoperfusion: a critical feature in unravelling the etiology of vascular cognitive impairment. Acta Neuropathol Commun. 2023;11(93):20230612. https:\/\/doi.org\/10.1186\/s40478-023-01590-1.","journal-title":"Acta Neuropathol Commun"},{"issue":"e3725","key":"5054_CR28","doi-asserted-by":"publisher","first-page":"20231004","DOI":"10.1002\/dmrr.3725","volume":"40","author":"R Agius","year":"2024","unstructured":"Agius R, Pace NP, Fava S. Phenotyping obesity: A focus on metabolically healthy obesity and metabolically unhealthy normal weight. Diabetes Metab Res Rev. 2024;40(e3725):20231004. https:\/\/doi.org\/10.1002\/dmrr.3725.","journal-title":"Diabetes Metab Res Rev"},{"issue":"2019\u20132027","key":"5054_CR29","doi-asserted-by":"publisher","first-page":"20130605","DOI":"10.3390\/nu5062019","volume":"5","author":"P Patel","year":"2013","unstructured":"Patel P, Abate N. Body fat distribution and insulin resistance. Nutrients. 2013;5(2019\u20132027):20130605. https:\/\/doi.org\/10.3390\/nu5062019.","journal-title":"Nutrients"},{"issue":"11","key":"5054_CR30","doi-asserted-by":"publisher","first-page":"20200415","DOI":"10.1038\/s41467-020-15686-y","volume":"2020","author":"S Kullmann","year":"1841","unstructured":"Kullmann S, Valenta V, Wagner R, et al. Brain insulin sensitivity is linked to adiposity and body fat distribution. Nat Commun. 1841;2020(11):20200415. https:\/\/doi.org\/10.1038\/s41467-020-15686-y.","journal-title":"Nat Commun"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-026-05054-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-026-05054-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-026-05054-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:05:14Z","timestamp":1790773514000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12883-026-05054-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,3]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5054"],"URL":"https:\/\/doi.org\/10.1186\/s12883-026-05054-6","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,3]]},"assertion":[{"value":"13 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval was obtained from the Peking University Institutional Review Board (IRB00001052-11015) in accordance with the Declaration of Helsinki. All participants provided signed informed consent.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"613"}}